EMCDDA Drugs Library

Continued signs of resilience in the European drug market: Highlights from the EMCDDA’s 2016 European drug report


This article synthesizes data on European drug markets collected and analysed by the EMCDDA in 2016.

Main subject: 


EMCDDA markets


This abstract is provided here as a convenience only. Check the publisher's website (if available) for the definitive version.

There is no abstract for this article.